Fig. 2From: Higher number of multidisciplinary tumor board meetings per case leads to improved clinical outcomeResponse to treatment: Grouped bar chart of the response to treatment by RECIST criteria of patients with and without a MTB in their history (n = 454, chi-square = 0.688)Back to article page